Dermatology
Dermatology practices providing medical, surgical, and cosmetic skin care services including Mohs surgery and injectables.
- 4
- Verticals
Overview
Dermatology practices provide medical, surgical, and cosmetic skin care, including Mohs surgery and cosmetic injectables. It was one of the earliest and most aggressive physician-specialty roll-ups, prized for its blend of recurring medical visits, cash-pay cosmetic upside, and ancillary pathology.
PE-backed dermatology platforms consolidated thousands of practices, though the model has faced some integration and reimbursement headwinds. Cosmetic demand and aging-related skin care underpin durable demand.
Market snapshot
Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so dermatology is not separately sized.
Business model & economics
Revenue model
Medical reimbursement plus cash-pay cosmetic and pathology
Key economics
- Recurring revenue
- Moderate–High
- EBITDA margin
- 20–30%
- Capex intensity
- Low
recurring medical and cosmetic visits
Characteristics
- One of the earliest and hottest specialty roll-ups.
- Recurring medical plus cash-pay cosmetic upside.
- Ancillary pathology enhances economics.
M&A deal context
Who’s acquiring
- PE-backed dermatology platforms
- Specialty MSO consolidators
- Aesthetics-aligned acquirers
What’s driving deals
- Continued roll-up of dermatology practices.
- Cosmetic and aging-skin demand.
- Ancillary-pathology economics.
Verticals in this segment
Find Dermatology acquisition targets
Search Acquisera’s index for companies classified under Dermatology (4.10.6) and build a targeted deal pipeline.
Search companies